Credit Suisse’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11
| Closed | – | – | 4217 |
|
|
2022
Q2 | $0 | Sell |
11
-11,060
| -100% | – | ﹤0.01% | 4214 |
|
|
2022
Q1 | $68K | Buy |
11,071
+977
| +10% | +$6K | ﹤0.01% | 3484 |
|
|
2021
Q4 | $127K | Sell |
10,094
-230
| -2% | -$2.89K | ﹤0.01% | 3508 |
|
|
2021
Q3 | $946K | Buy |
10,324
+715
| +7% | +$65.5K | ﹤0.01% | 2622 |
|
|
2021
Q2 | $509K | Sell |
9,609
-1,746
| -15% | -$92.5K | ﹤0.01% | 3006 |
|
|
2021
Q1 | $409K | Sell |
11,355
-17,420
| -61% | -$627K | ﹤0.01% | 3051 |
|
|
2020
Q4 | $799K | Buy |
28,775
+20,813
| +261% | +$578K | ﹤0.01% | 2711 |
|
|
2020
Q3 | $399K | Sell |
7,962
-1,439
| -15% | -$72.1K | ﹤0.01% | 2780 |
|
|
2020
Q2 | $435K | Buy |
+9,401
| New | +$435K | ﹤0.01% | 2770 |
|
|
2019
Q3 | – | Sell |
-6,792
| Closed | -$289K | – | 3478 |
|
|
2019
Q2 | $289K | Buy |
+6,792
| New | +$289K | ﹤0.01% | 3059 |
|